The Impacts of impurity presence in medicines: The research evolution for patient safety
das Brasilien-Zentrum der Universität Tübingen lädt Sie zum „The Impacts of impurity presence in medicines: The research evolution for patient safety“ mit Dr. Natanael Dante Segretti und Dr. Mariah Ultramari von der Spektra Soluções Científicas, Brazil ein.
Active pharmaceutical ingredients (APIs) can degrade when exposed to environmental variables (such as light, high temperatures, humidity, among others) leading to the formation of various impurities with high toxicological potential. In addition, interactions between actives and excipients, between the formulation and packaging, with the equipment of the production process, and the active synthesis route itself, can also directly contribute to the contamination of products by these unwanted compounds. Thus, there is growing concern about the presence of impurities in pharmaceutical products since there is no risk-benefit ratio for these compounds. This theme has driven scientific evolution to ensure the delivery of higher quality and safer products to patients.